Targeted p21WAF1/CIP1 activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 34, Issue 2, 2016, Pages 59.e23-59.e34

  Wang, Chenghe ^a   Tang, Kun ^a   Li, Zhen ^b   Chen, Zhong ^a   Xu, Hua ^a   Ye, Zhangqun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

miR 1236; p21 (Cip1 Waf1); Prognosis; Proliferation; Renal cell carcinoma; RNAa

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; MICRORNA; MICRORNA 1236; PROTEIN P21; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MIRN1236 MICRORNA, HUMAN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY;

AGED; CARCINOMA, RENAL CELL; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84945400027     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2015.08.014     Document Type: Article

References (27)

1. [1] Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006), 106–130.
2. [2] Bozkurt, O., Inanc, M., Hacibekiroglu, I., Esbah, O., Seker, M., Ulas, A., et al. Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO). Anticancer Res 34 (2014), 4463–4470.
3. [3] Beraza, N., Trautwein, C., Restoration of p53 function: a new therapeutic strategy to induce tumor regression?. Hepatology 45 (2007), 1578–1579.
4. [4] el-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54 (1994), 1169–1174.
5. [5] Abbas, T., Dutta, A., p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9 (2009), 400–414.
6. [6] Place, R.F., Noonan, E.J., Giardina, C., HDACs and the senescent phenotype of WI-38 cells. BMC Cell Biol, 6, 2005, 37.
7. [7] Poole, A.J., Heap, D., Carroll, R.E., Tyner, A.L., Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene 23 (2004), 8128–8134.
8. [8] Garzon, R., Pichiorri, F., Palumbo, T., Visentini, M., Aqeilan, R., Cimmino, A., et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26 (2007), 4148–4157.
9. [9] Ambros, V., microRNAs: tiny regulators with great potential. Cell 107 (2001), 823–826.
10. [10] Huang, V., Place, R.F., Portnoy, V., Wang, J., Qi, Z., Jia, Z., et al. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res 40 (2012), 1695–1707.
11. [11] Kosaka, M., Kang, M.R., Yang, G., Li, L.C., Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther 22 (2012), 335–343.
12. [12] Chen, Z., Place, R.F., Jia, Z.J., Pookot, D., Dahiya, R., Li, L.C., Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther 7 (2008), 698–703.
13. [13] Wang, C., Chen, Z., Ge, Q., Hu, J., Li, F., Hu, J., et al. Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications in bladder cancer cells. FEBS Lett 588 (2014), 4654–4664.
14. [14] Li, L.C., Okino, S.T., Zhao, H., Pookot, D., Place, R.F., Urakami, S., et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 103 (2006), 17337–17342.
15. [15] Jiao, A.L., Slack, F.J., RNA-mediated gene activation. Epigenetics 9 (2014), 27–36.
16. [16] Ishihara, T., Seki, N., Inoguchi, S., Yoshino, H., Tatarano, S., Yamada, Y., et al. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. J Urol 192 (2014), 1822–1830.
17. [17] Heinzelmann, J., Henning, B., Sanjmyatav, J., Posorski, N., Steiner, T., Wunderlich, H., et al. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. World J Urol 29 (2011), 367–373.
18. [18] Place, R.F., Noonan, E.J., Foldes-Papp, Z., Li, L.C., Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol 11 (2010), 518–526.
19. [19] Li, W., Fan, J., Banerjee, D., Bertino, J.R., Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein. Mol Pharmacol 55 (1999), 1088–1093.
20. [20] Dong, Z., Dang, Y., Chen, Y., Small double-stranded RNA mediates the anti-cancer effects of p21WAF1/ClP1 transcriptional activation in a human glioma cell line. Yonsei Med J 55 (2014), 324–330.
21. [21] Liu, W., Yang, Y., Liu, Y., Liu, H., Zhang, W., Xu, L., et al. p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma. Urol Oncol 33 (2015), 205.e13–205.e21.
22. [22] Weiss, R.H., Borowsky, A.D., Seligson, D., Lin, P.Y., Dillard-Telm, L., Belldegrun, A.S., et al. p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches. J Urol 177 (2007), 63–68 [discussion 8-9].
23. [23] Gartel, A.L., Tyner, A.L., The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1 (2002), 639–649.
24. [24] Wu, Z.M., Dai, C., Huang, Y., Zheng, C.F., Dong, Q.Z., Wang, G., et al. Anti-cancer effects of p21WAF1/CIP1 transcriptional activation induced by dsRNAs in human hepatocellular carcinoma cell lines. Acta Pharmacol Sin 32 (2011), 939–946.
25. [25] Yang, K., Zheng, X.Y., Qin, J., Wang, Y.B., Bai, Y., Mao, Q.Q., et al. Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett 265 (2008), 206–214.
26. [26] Zeng, Y., Yi, R., Cullen, B.R., MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A 100 (2003), 9779–9784.
27. [27] Place, R.F., Li, L.C., Pookot, D., Noonan, E.J., Dahiya, R., MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105 (2008), 1608–1613.